Ngm Biopharmaceuticals shares owned by Wells Fargo & Company
Quarter-by-quarter ownership of Ngm Biopharmaceuticals (NGM) shares owned by Wells Fargo & Company
from 13F filings
Historical chart of Wells Fargo & Company investment in Ngm Biopharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Ngm Biopharmaceuticals held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Ngm Biopharmaceuticals by Wells Fargo & Company
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-03-31 | $25k | 15k | 1.59 |
2023-12-31 | $12k | 14k | 0.86 |
2023-09-30 | $12k | 11k | 1.07 |
2023-06-30 | $44k | 17k | 2.59 |
2022-12-31 | $5.0k | 1.0k | 5.02 |
2022-09-30 | $19k | 1.5k | 13.07 |
2022-06-30 | $24k | 1.9k | 13.00 |
2022-03-31 | $193k | 13k | 15.25 |
2021-12-31 | $334k | 19k | 17.74 |
2021-09-30 | $384k | 18k | 20.97 |
2021-06-30 | $867k | 43k | 20.00 |
2021-03-31 | $460k | 16k | 29.11 |
2020-12-31 | $1.1M | 36k | 30.26 |
2020-09-30 | $813k | 51k | 15.91 |
2020-06-30 | $1.7M | 84k | 19.74 |
2020-03-31 | $458k | 37k | 12.34 |
2019-12-31 | $469k | 25k | 18.52 |
2019-09-30 | $47k | 3.4k | 13.78 |
2019-06-30 | $1.0k | 50 | 20.00 |